Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

International Journal of Cancer

Volumn 104, Issue 3, 2003, Pages 354-361

  Jinushi, Masahisa ^a   Takehara, Tetsuo ^a   Tatsumi, Tomohide ^a   Kanto, Tatsuya ^a   Groh, Veronika ^b   Spies, Thomas ^b   Kimura, Ritsuko ^a   Miyagi, Takuya ^a   Mochizuki, Kiyoshi ^a   Sasaki, Yutaka ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

All trans retinoic acid; Human hepatocellular carcinoma; MICA B; NK cells

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICA PROTEIN; MICB PROTEIN; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; EFFECTOR CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEPATOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037431424     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10966     Document Type: Article

References (34)

1. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997;25:259-62.
2. Norris S, Collins C, Doherty DG, Smith F. McEntee G, Traynor O, Nolan NN, Hegarty J, O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998;28:84-90.
3. Goossens PL, Jouin H, Marchel G, Milon G. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J Immunol Methods 1990;132:137-44.
4. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma. Cancer 1998;83:58-63.
5. Kawabayashi N, Seki S, Hatsuse K, Ohkawa T. Koike Y, Aihara T, Habu T, Nakagawa R, Ami K, Hiraide H, Mochizuki H. Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000;32:962-9.
6. Smyth MJ, Thia KY, Street SEA, Cretney E, Trapani JA, Taniguchi M, Kawano TT, Pelikan SB, Crowe NY, Godfrey D. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000;191:661-8.
7. Kim S, Iizyka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000;97:2731-6.
8. Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990;11:237-44.
9. Lanier LL. NK cell receptors. Annu Rev Immunol Today 1990;237-44.
10. Lanier LL. Turning on natural killer cells. J Exp Med 1998;191:1259-62.
11. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari NC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
12. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9.
13. Wu J, Song Y, Bakker ABH. Bauer S, Spies T, Lanier LL, Phillips JH. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285:730-2.
14. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced molecules by intestinal epithelium γ δ T cells. Science 1998;279;1737-40.
15. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1999;93:12445-50.
16. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived γ δ T cells of MICA and MICB. Proc Natl Acad Sci USA 1999;96:6879-84.
17. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8 α β T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001;2:255-60.
18. Das H, Groh V, Kuiji C, Sugita M, Morita CT, Spies T, Bukowski JF. MICA engagement by human VγVδ2 T cells enhances their antigen-dependent effector function. Immunity 2001;15:83-93.
19. Tieng V, Bouguenec CL, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC Class I-related molecule MICA. Proc Natl Acad Sci USA 2002;99:2977- 82.
20. Cerwenka A, Bakker ABH, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000;12:721-7.
21. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2001;1:119-26.
22. Carbone E, Ruggiero G, Terrazzano G. Palomba C, Manzo C, Fontana S, Spits H. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997;185:2053-60.
23. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ. ULBPs, novel MHC Class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001;14:123-33.
24. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 1992;89:7129-33.
25. Tayebi H, Lienard M, Billot P, Tiberghien P, Herbe P, Robinet E. Detection of intracellular cytokines in citrated whole blood or marrow samples by flow cytometry. J Immunol Methods 1999;229:121-30.
26. Alexander CL, Edward M, MacKie RM. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and effect of retinoic acid. Br J Cancer 1999;80:1494-500.
27. Sun SY, Yue P, Hong WK, Lotan R. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res 2001;62:6537-43.
28. Santin AD, Hermonat P, Ravaggi A. Chiriva-Internati M, Hiserodt JC, Tian E, Carter CA, Pecorelli S, Parham GP. Effects of retinoic acid combined with interferon-γ on the expression of major-histocompatibility complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer 1998;75:254-8.
29. Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Mulberg J, Rousseau AM, Ulrich D, Armitage R. ULBP1, 2, 3: novel MHC Class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol 2001;31:1428-37.
30. Miller WHJ. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998;83:1471-82.
31. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Makamura T, Kojima T. Preventions of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-7.
32. Muto Y, Moriwaki H, Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med 1999;340:1046-7.
33. Yamada Y, Shidoji Y, Fukutomi Y, Ishikawa T, Kaneko T, Nakagawa H, Imawari M, Moriwaki H, Muto Y. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines. Mol Carcinog 1994;10:151-8.
34. Nakamura N, Shidoji Y, Yamada Y, Hatakeyama H, Muto Y. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, Huh-7. Biochem Biophys Res Commun 1995;207:382-8.